Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application. - Wikidata - wikimedia - TriplyDB

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.

http://www.wikidata.org/entity/Q37671216

about

Aberrant control of NF-κB in cancer permits transcriptional and phenotypic plasticity, to curtail dependence on host tissue: molecular mode.Development of DNA tetrahedron-based drug delivery system.

P2860

Q41514200-03E15CE4-2A63-4D49-B5B8-CB72C51AD2CE Q50166324-E67EC11B-F52B-4D97-9C76-25C988AF31EB

P2860

Heterogeneity of Toll-like receptor 9 signaling in B cell malignancies and its potential therapeutic application.

http://www.wikidata.org/entity/Q37671216

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 27 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@en

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@nl

type

label

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@en

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@nl

prefLabel

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@en

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@nl

P1433

Q37671216-A7BC4802-8A95-4F27-AC61-9D9F72A28FE3

P1476

Q37671216-21C8C633-09DD-4E3A-8297-B623915EC63E

P2093

Q37671216-26F22E4B-15C2-41F3-AD00-744F73AB1EC1

Q37671216-4355C44B-1209-4342-B448-1D5C0970700D

Q37671216-450F9A0A-2440-4607-96EE-FBBC75EC389A

Q37671216-59AF81CA-9F10-49D0-AE2C-D7B63896F250

Q37671216-ACFDAB84-D66C-4C46-A70D-7E512F8C610D

Q37671216-EB6593B3-8A92-43D1-B7DB-A4984E9B3D8E

Q37671216-F3506016-9BA2-4B8B-A829-5AD395BD9013

Q37671216-FF127DCD-BEE2-48C8-AF9C-9E7CA714E234

P275

Q37671216-E4149D30-76D6-4BD6-A56A-46CF9D2B4BCD

P2860

Q37671216-0696487C-96A5-476C-8686-A4844A762D1F

Q37671216-09E25338-E5D4-4CBC-9245-EE2D4BD11565

Q37671216-11FF01A2-59ED-4747-89E2-FFE7976A0816

Q37671216-1554B555-7ECE-4A86-8DE8-E4C793F41C0A

Q37671216-17810644-569B-468E-836D-C0243581C466

Q37671216-1D330EA3-08F1-43C1-AA4C-CFFC0C8A815D

Q37671216-1D3A10DB-0E4B-4C54-93CE-51B69E76C51E

Q37671216-1E6706F4-DE5A-4F06-B85B-3A0B0C182065

Q37671216-1F80C361-349F-4A71-A88D-241AEA37748C

Q37671216-1FAE2513-34CD-4FCA-9086-1E232B944059

P2888

Q37671216-3925C812-D89A-43E2-A26C-34C83A31CAA8

P304

Q37671216-CB348854-4F62-4C63-BD55-3CEAB2E6C045

P31

Q37671216-36392992-C581-491C-AACA-6864F4D34E4E

Q37671216-E1145517-803C-494D-A60D-3C0FEF937331

P356

Q37671216-79E2A114-4333-4BD0-A35D-D76AEF661E07

P433

Q37671216-A7CD47AA-1A10-47CB-B187-D0628DE65B8C

P478

Q37671216-BC2F58E7-67D1-4698-926A-602E2FC988B5

P577

Q37671216-AF9C11A6-8041-4941-B170-2A87A921B5D7

P6179

Q37671216-7E190106-AAA2-4A32-9BF3-97E02265CBE8

P698

Q37671216-54FF4650-8D0A-4284-8FD7-2CD406C71444

P921

Q37671216-266C2327-55FA-4166-A9B3-1BA9371C00A2

Q37671216-3807A847-98FE-4B3E-BB35-05A00CE29C56

Q37671216-87BF9329-F758-45C5-B766-ED728717248F

Q37671216-EF4572EA-BD35-4649-AF6F-80B7F2E33E7A

Q37671216-F17AE23D-D1C7-4166-8FB7-5CBB6CA29F0F

P932

Q37671216-933C434D-484F-4E4D-A5CE-B0C60F951230

P356

S12967-017-1152-5

P1433

Journal of Translational Medicine

P1476

Heterogeneity of Toll-like rec ...... ntial therapeutic application.

@en

P2093

Chao Niu

http://www.w3.org/2001/XMLSchema#string

Jingtao Chen

http://www.w3.org/2001/XMLSchema#string

Jiuwei Cui

http://www.w3.org/2001/XMLSchema#string

Lei Zhou

http://www.w3.org/2001/XMLSchema#string

Ling Bai

http://www.w3.org/2001/XMLSchema#string

Wei Chen

http://www.w3.org/2001/XMLSchema#string

Wei Han

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

Anti-CD19 Monoclonal Antibodies: a New Approach to Lymphoma Therapy

Lymphoma Immunotherapy: Current Status

Targeted Therapies in Adult B-Cell Malignancies

CD19-Chimeric Antigen Receptor T Cells for Treatment of Chronic Lymphocytic Leukaemia and Acute Lymphoblastic Leukaemia

CpG-rich islands and the function of DNA methylation

On watching the watchers: IDO and type I/II IFN

Oncogenically active MYD88 mutations in human lymphoma

Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88

Toll-like receptors: critical proteins linking innate and acquired immunity

P2888

s12967-017-1152-5

P304

51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-017-1152-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2017-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1084251480

http://www.w3.org/2001/XMLSchema#string

P698

28241765

http://www.w3.org/2001/XMLSchema#string

P921

DNA-binding protein

cell surface receptor

Toll-like receptor

pattern recognition receptors

membrane proteins

P932

5329966

http://www.w3.org/2001/XMLSchema#string